
| 2019 | |
|---|---|
| Criterium: | Position: | 
| Overall Score: | > 1000 | 
| Total Project Funding per Partner: | > 1000 | 
| Total Number of Projects: | > 1000 | 
									Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 8.413.640 | 209.063 | 2 | ||
| 2019 | 0 | 63.273.831 | 311.900 | 2 | ||
							Total number of partners: 157
							Partner loyalty:
Frequent Partner: (> 2 projects): 15
Rare Partner: 142
Frequent / Rare Partner Ratio: 0.11
						
| Start date | Project | acronym | role | funding | partners | 
|---|---|---|---|---|---|
| 2021-05-01 | PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL | TTV GUIDE TX | participant | 6.099.831 | 21 | 
| 2021-03-01 | European Rare dIsease research Coordination and support Action | ERICA | participant | 2.313.809 | 27 | 
| 2019-01-01 | European Joint Programme on Rare Diseases | EJP RD | participant | 55.073.831 | 88 | 
| 2019-01-01 | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | NECESSITY | participant | 8.200.000 | 25 |